Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Abstract 1254: Integration of human omics analysis and new syngeneic tumor organoid models reveals that aberrant RAS/PI3K crosstalk triggers refractoriness in high-grade serous carcinoma

Tomohiro Tamura, Kenta Masuda, Shimpei Nagai, Keiyo Imaeda, Juntaro Yamasaki, Eiji Sugihara, Hiroyuki Nobusue, Yuji Otsuki, Rui Yamaguchi, Kazuhiro Sakurada, Wataru Yamagami, Hideyuki Saya, Osamu Nagano

Cancer Res (2024) 84 (6_Supplement): 1254.

https://doi.org/10.1158/1538-7445.AM2024-1254

Published: 22 March 2024

View article titled, Abstract 1254: Integration of human omics analysis and new syngeneic tumor organoid models reveals that aberrant RAS/PI3K crosstalk triggers refractoriness in high-grade serous carcinoma

Journal Articles

Abstract 1227: Esophageal cancer shows spontaneous plasticity between epithelial and mesenchymal status

Kenji Tsuchihashi, Yuki Hirata, Juntaro Yamasaki, Kentaro Suina, Kenro Tanoue, Toshifumi Yae, Kenta Masuda, Eishi Baba, Koichi Akashi, Yuko Kitagawa, Hideyuki Saya, Osamu Nagano

Cancer Res (2023) 83 (7_Supplement): 1227.

https://doi.org/10.1158/1538-7445.AM2023-1227

Published: 04 April 2023

View article titled, Abstract 1227: Esophageal cancer shows spontaneous plasticity between epithelial and mesenchymal status

Journal Articles

Stromal Reprogramming through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors

Cancer Res (2023) 83 (5): 753–770.

https://doi.org/10.1158/0008-5472.CAN-22-1890

Published: 02 March 2023

View article titled, Stromal Reprogramming through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors

Includes: Supplementary data

Journal Articles

Abstract 2019: Drug repositioning to induce the synthetic lethality in cancer cells with GSH-depleting therapy

Yuji Otsuki, Osamu Nagano, Hideyuki Saya

Cancer Res (2021) 81 (13_Supplement): 2019.

https://doi.org/10.1158/1538-7445.AM2021-2019

Published: 01 July 2021

View article titled, Abstract 2019: Drug repositioning to induce the synthetic lethality in cancer cells with GSH-depleting therapy

Journal Articles

Abstract 3579: Pimozide combined with paclitaxel demonstrates a significant antitumor effect in head and neck squamous cell carcinoma

Shintaro Nakamura, Hiroyuki Ozawa, Juntaro Yamasaki, Shogo Okazaki, Momoko Yoshikawa, Tomoya Soma, Seiji Asoda, Osamu Nagano, Mariko Sekimizu, Shin Saito, Keisuke Yoshihama, Takuya Mikoshiba, Kaoru Ogawa, Hideyuki Saya

Cancer Res (2020) 80 (16_Supplement): 3579.

https://doi.org/10.1158/1538-7445.AM2020-3579

Published: 15 August 2020

View article titled, Abstract 3579: Pimozide combined with paclitaxel demonstrates a significant antitumor effect in head and neck squamous cell carcinoma

Journal Articles

Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma

Takashi Sato, Seungyeul Yoo, Ranran Kong, Abhilasha Sinha, Prashanth Chandramani-Shivalingappa, Ayushi Patel, Maya Fridrikh, Osamu Nagano, Takashi Masuko, Mary Beth Beasley, Charles A. Powell, Jun Zhu, Hideo Watanabe

Cancer Res (2019) 79 (24): 6084–6100.

https://doi.org/10.1158/0008-5472.CAN-19-2132

Published: 13 December 2019

View article titled, Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma

Includes: Supplementary data

Journal Articles

Abstract 4639: SLC7A11 expression confers cancer stem-like properties in small cell lung cancer cells

Shohei Kamenori, Kentaro Suina, Juntaro Yamasaki, Subaru Shintani, Yuji Otsuki, Yuki Hirata, Shogo Okazaki, Kenji Tsuchihashi, Oltea Sampetrean, Yoichiro Mitsuishi, Fumiyuki Takahashi, Kazuhisa Takahashi, Hideyuki Saya, Osamu Nagano

Cancer Res (2019) 79 (13_Supplement): 4639.

https://doi.org/10.1158/1538-7445.AM2019-4639

Published: 01 July 2019

View article titled, Abstract 4639: <em>SLC7A11</em> expression confers cancer stem-like properties in small cell lung cancer cells

Journal Articles

Abstract 2156: Lung niche factors for progenitor cell self-renewal sustain lung cancer stem cells and contribute to drug resistance to kinase inhibitors in non-small cell lung cancer

Akinori Mitsui, Sachiko Yokokawa, Osamu Nagano, Hideyuki Saya

Cancer Res (2018) 78 (13_Supplement): 2156.

https://doi.org/10.1158/1538-7445.AM2018-2156

Published: 01 July 2018

View article titled, Abstract 2156: Lung niche factors for progenitor cell self-renewal sustain lung cancer stem cells and contribute to drug resistance to kinase inhibitors in non-small cell lung cancer

Journal Articles

Abstract LB-334: xCT promotes malignant phenotypes in EGFR-expressing glioma

Kenji Tsuchihashi, Shogo Okazaki, Momoko Yoshikawa, Ryo Seishima, Oltea Sampetrean, Nobuyuki Onishi, Hiroaki Wakimoto, Frank Furnari, Eishi Baba, Koichi Akashi, Hideyuki Saya, Osamu Nagano

Cancer Res (2017) 77 (13_Supplement): LB-334.

https://doi.org/10.1158/1538-7445.AM2017-LB-334

Published: 01 July 2017

View article titled, Abstract LB-334: xCT promotes malignant phenotypes in EGFR-expressing glioma

Journal Articles

Abstract 432: xCT inhibition disrupts redox homeostasis in CD44v-expressing tumor cells showing glutaminolytic metabolism in head and neck squamous cell carcinoma

Shogo Okazaki, Kenji Tsuchihashi, Oltea Sampetrean, Hideyuki Saya, Osamu Nagano

Cancer Res (2017) 77 (13_Supplement): 432.

https://doi.org/10.1158/1538-7445.AM2017-432

Published: 01 July 2017

View article titled, Abstract 432: xCT inhibition disrupts redox homeostasis in CD44v-expressing tumor cells showing glutaminolytic metabolism in head and neck squamous cell carcinoma

Journal Articles

The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc( — )

Cancer Res (2016) 76 (10): 2954–2963.

https://doi.org/10.1158/0008-5472.CAN-15-2121

Published: 12 May 2016

View article titled, The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc( — )

Includes: Supplementary data

Journal Articles

Abstract 4967: ESRP1 regulated alternative splicing of CD44mRNA enhances lung colonization of metastatic cancer cell

Cancer Res (2014) 74 (19_Supplement): 4967.

https://doi.org/10.1158/1538-7445.AM2014-4967

Published: 01 October 2014

View article titled, Abstract 4967: ESRP1 regulated alternative splicing of CD44mRNA enhances lung colonization of metastatic cancer cell

Journal Articles

Abstract 211: Sulfasalazine (SSZ) works cancer stem-like cells (CSCs) via inhibiting xCT signal pathway: Phase 1 study in patients with gastric cancer (EPOC 1205)

Kohei Shitara, Shunji Takahashi, Takako Nakajima, Hironaka Shuichi, Osamu Nagano, Chiyo Imamura, Taisei Mushiroda, Yasuaki Einaga, Miki Fukunani, Akihiro Sato, Atsushi Ohtsu, Hideyuki Saya, Toshihiko Doi

Cancer Res (2014) 74 (19_Supplement): 211.

https://doi.org/10.1158/1538-7445.AM2014-211

Published: 01 October 2014

View article titled, Abstract 211: Sulfasalazine (SSZ) works cancer stem-like cells (CSCs) via inhibiting xCT signal pathway: Phase 1 study in patients with gastric cancer (EPOC 1205)

Journal Articles

Abstract 65: Ink4a/Arf locus drives gastric tumorigenesis through induction of parietal cell loss

Ryo Seishima, Takeyuki Wada, Hirotoshi Hasegawa, Yoshiyuki Ishii, Koji Okabayashi, Masashi Tsuruta, Yuko Kitagawa, Hideyuki Saya, Osamu Nagano

Cancer Res (2014) 74 (19_Supplement): 65.

https://doi.org/10.1158/1538-7445.AM2014-65

Published: 01 October 2014

View article titled, Abstract 65: <em>Ink4a/Arf</em> locus drives gastric tumorigenesis through induction of parietal cell loss

Journal Articles

Abstract C89: ESRP1-CD44v-xCT axis as a potential therapeutic target for the metastasis

Go J. Yoshida, Kenji Tsuchihashi, Toshifumi Yae, Osamu Nagano, Hideyuki Saya

Cancer Res (2013) 73 (3_Supplement): C89.

https://doi.org/10.1158/1538-7445.TIM2013-C89

Published: 01 May 2014

View article titled, Abstract C89: ESRP1-CD44v-xCT axis as a potential therapeutic target for the metastasis

Journal Articles

Abstract 3719: xCT inhibition suppresses CD44v-positive stem-like tumor cells, which are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma.

Momoko Yoshitake, Osamu Nagano, Taneaki Nakagawa, Hideyuki Saya

Cancer Res (2013) 73 (8_Supplement): 3719.

https://doi.org/10.1158/1538-7445.AM2013-3719

Published: 15 April 2013

View article titled, Abstract 3719: xCT inhibition suppresses CD44v-positive stem-like tumor cells, which are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma.

Journal Articles

xCT Inhibition Depletes CD44v-Expressing Tumor Cells That Are Resistant to EGFR-Targeted Therapy in Head and Neck Squamous Cell Carcinoma

Momoko Yoshikawa, Kenji Tsuchihashi, Takatsugu Ishimoto, Toshifumi Yae, Takeshi Motohara, Eiji Sugihara, Nobuyuki Onishi, Takashi Masuko, Kunio Yoshizawa, Shuichi Kawashiri, Makio Mukai, Seiji Asoda, Hiromasa Kawana, Taneaki Nakagawa, Hideyuki Saya, Osamu Nagano

Cancer Res (2013) 73 (6): 1855–1866.

https://doi.org/10.1158/0008-5472.CAN-12-3609-T

Published: 14 March 2013

View article titled, xCT Inhibition Depletes CD44v-Expressing Tumor Cells That Are Resistant to EGFR-Targeted Therapy in Head and Neck Squamous Cell Carcinoma

Includes: Supplementary data

Journal Articles

CD44s Regulates the TGF-β–Mediated Mesenchymal Phenotype and Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma

Kosuke Mima, Hirohisa Okabe, Takatsugu Ishimoto, Hiromitsu Hayashi, Shigeki Nakagawa, Hideyuki Kuroki, Masayuki Watanabe, Toru Beppu, Mayumi Tamada, Osamu Nagano, Hideyuki Saya, Hideo Baba

Cancer Res (2012) 72 (13): 3414–3423.

https://doi.org/10.1158/0008-5472.CAN-12-0299

Published: 01 July 2012

View article titled, CD44s Regulates the TGF-β–Mediated Mesenchymal Phenotype and Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma

Includes: Supplementary data

Journal Articles

Abstract 4436: Chronic inflammation and gastric carcinogenesis: the role of CD44 variant expression

Takeyuki Wada, Osamu Nagano, Takatsugu Ishimoto, Toshifumi Yae, Yuko Kitagawa, Hideyuki Saya

Cancer Res (2012) 72 (8_Supplement): 4436.

https://doi.org/10.1158/1538-7445.AM2012-4436

Published: 15 April 2012

View article titled, Abstract 4436: Chronic inflammation and gastric carcinogenesis: the role of CD44 variant expression

Journal Articles

Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells

Mayumi Tamada, Osamu Nagano, Seiji Tateyama, Mitsuyo Ohmura, Toshifumi Yae, Takatsugu Ishimoto, Eiji Sugihara, Nobuyuki Onishi, Takehiro Yamamoto, Hiroshi Yanagawa, Makoto Suematsu, Hideyuki Saya

Cancer Res (2012) 72 (6): 1438–1448.

https://doi.org/10.1158/0008-5472.CAN-11-3024

Published: 14 March 2012

View article titled, Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells

Includes: Supplementary data

NARROW

Abstract 1254: Integration of human omics analysis and new syngeneic tumor organoid models reveals that aberrant RAS/PI3K crosstalk triggers refractoriness in high-grade serous carcinoma

Abstract 1227: Esophageal cancer shows spontaneous plasticity between epithelial and mesenchymal status

Stromal Reprogramming through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors

Abstract 2019: Drug repositioning to induce the synthetic lethality in cancer cells with GSH-depleting therapy

Abstract 3579: Pimozide combined with paclitaxel demonstrates a significant antitumor effect in head and neck squamous cell carcinoma

Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma

Abstract 4639: SLC7A11 expression confers cancer stem-like properties in small cell lung cancer cells

Abstract 2156: Lung niche factors for progenitor cell self-renewal sustain lung cancer stem cells and contribute to drug resistance to kinase inhibitors in non-small cell lung cancer

Abstract LB-334: xCT promotes malignant phenotypes in EGFR-expressing glioma

Abstract 432: xCT inhibition disrupts redox homeostasis in CD44v-expressing tumor cells showing glutaminolytic metabolism in head and neck squamous cell carcinoma

The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc( — )

Abstract 4967: ESRP1 regulated alternative splicing of CD44mRNA enhances lung colonization of metastatic cancer cell

Abstract 211: Sulfasalazine (SSZ) works cancer stem-like cells (CSCs) via inhibiting xCT signal pathway: Phase 1 study in patients with gastric cancer (EPOC 1205)

Abstract 65: Ink4a/Arf locus drives gastric tumorigenesis through induction of parietal cell loss

Abstract C89: ESRP1-CD44v-xCT axis as a potential therapeutic target for the metastasis

Abstract 3719: xCT inhibition suppresses CD44v-positive stem-like tumor cells, which are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma.

xCT Inhibition Depletes CD44v-Expressing Tumor Cells That Are Resistant to EGFR-Targeted Therapy in Head and Neck Squamous Cell Carcinoma

CD44s Regulates the TGF-β–Mediated Mesenchymal Phenotype and Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma

Abstract 4436: Chronic inflammation and gastric carcinogenesis: the role of CD44 variant expression

Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only